Pharma major, Dr Reddy's Laboratories registered a fall in net by 34 per cent at Rs 79.2 crore (Rs 792 million) during first quarter ending June 30 while the total revenue has showed a growth of 6 per cent.
The net income slided from Rs 119.4 crore (Rs 1.19 billion) in the first quarter of the previous year to Rs 79.2 crore (Rs 792 million) for the same period this fiscal, a company release said on Thursday.
While total revenue was marginally up by six per cent with the quarter showing Rs 481.2 crore (Rs 4.81 billion) against the previous year's figure of Rs 453.3 crore (Rs 4.53 billion), it said.
Operating profit dropped by 31 per cent at Rs 84.2 crore (Rs 842 million), the previous year figure being Rs 121.4 crore (Rs 1.21 billion).
Revenues outside India contributed to 64 per cent at Rs 306.3 crore (Rs 3.06 billion) recording a 7 per cent growth year-on-year of which Rs 155.4 crore (Rs 1.55 billion) was from North America as against Rs 165.7 crore (Rs 1.66 billion) in the same period last fiscal, the release added.
Revenue from Europe was Rs 41.2 crore (Rs 412 million) as against Rs 32.2 crore (Rs 322 million) during last fiscal registering a year-on-year growth of 28 per cent while income from Russia went up by 27 per cent, the release added.
